Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H15NO3 |
Molecular Weight | 149.1882 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN(CCO)CCO
InChI
InChIKey=GSEJCLTVZPLZKY-UHFFFAOYSA-N
InChI=1S/C6H15NO3/c8-4-1-7(2-5-9)3-6-10/h8-10H,1-6H2
Molecular Formula | C6H15NO3 |
Molecular Weight | 149.1882 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TROLAMINE&audience=professional;Curator's Comment: Description was created using several sources including:
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/11340s16lbl.pdf; https://www.ons.org/intervention/trolamine-biafine®; https://www.ncbi.nlm.nih.gov/pubmed/?term=15084618; https://clinicaltrials.gov/ct2/show/NCT02729324; http://www.ncbi.nlm.nih.gov/pubmed/18441842
Sources: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TROLAMINE&audience=professional;
Curator's Comment: Description was created using several sources including:
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/11340s16lbl.pdf; https://www.ons.org/intervention/trolamine-biafine®; https://www.ncbi.nlm.nih.gov/pubmed/?term=15084618; https://clinicaltrials.gov/ct2/show/NCT02729324; http://www.ncbi.nlm.nih.gov/pubmed/18441842
Trolamine, an organic compound, is the salt formed between triethanolamine and salicylic acid. It is widely used as a topical analgesic. 10% trolamine salicylate medical products sold over-the-counter such as are creams for temporarily relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, lumbago, neuralgia, strains, bruises, and sprains. The FDA approved in 1958 otic solution drops containing triethanolamine polypeptide used in the ear to break down and loosen earwax was discontinued. Trolamine can enhance skin healing by recruiting macrophages and modifying the concentrations of various immunomodulators. Trolamine (Biafine; Genmedix Ltd, France) is commonly prescribed at the beginning of radiotherapy for preventing acute radiation-induced skin toxicity in China. Biafine has been studied in radiodermatitis and Phase 2 clinical trial has been initiated in 2016 by Sun Yat-sen University to establish the efficacy of trolamine (Biafine) for the management of radiation dermatitis in patients with nasopharyngeal carcinoma receiving IMRT.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | Volu-Firm Approved UseUnknown |
|||
Palliative | CERUMENEX Approved UseFor removal of impacted cerumen prior to ear examination, otologic therapy and/or audiometry. CERUMENEX Eardrops should be used only with caution in external otitis. Launch Date1958 |
Doses
Dose | Population | Adverse events |
---|---|---|
5.38 mg 2 times / day multiple, topical Studied dose Dose: 5.38 mg, 2 times / day Route: topical Route: multiple Dose: 5.38 mg, 2 times / day Sources: |
unhealthy, 21.6–84.9 n = 15 Health Status: unhealthy Condition: Wound Age Group: 21.6–84.9 Sex: M+F Population Size: 15 Sources: |
Disc. AE: Application site erythema... AEs leading to discontinuation/dose reduction: Application site erythema (6.7%) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Application site erythema | 6.7% Disc. AE |
5.38 mg 2 times / day multiple, topical Studied dose Dose: 5.38 mg, 2 times / day Route: topical Route: multiple Dose: 5.38 mg, 2 times / day Sources: |
unhealthy, 21.6–84.9 n = 15 Health Status: unhealthy Condition: Wound Age Group: 21.6–84.9 Sex: M+F Population Size: 15 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Enantioselective separation of epoxides by capillary electrophoresis employing sulfated beta-cyclodextrin as chiral selector. | 2001 Apr |
|
Comparative studies of various run buffers for chiral capillary electrophoresis using chiral crown ether as a chiral selector. | 2001 Dec |
|
Bis(triethanolamine)cadmium(II) and -mercury(II) saccharinates: seven-coordinate complexes containing both tri- and tetradentate triethanolamine ligands. | 2001 Dec |
|
Extraction and separation of cationic surfactants from river sediments: application to a spectrophotometric determination of cationic surfactant in an aquatic environment using membrane filters. | 2001 Nov |
|
[Determination of sulfite residues in foods by using the modified rankine apparatus and HPLC]. | 2001 Oct |
|
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. | 2002 Apr 2 |
|
Quantitation of nicotine in tobacco products by capillary electrophoresis. | 2002 Jan-Feb |
|
Amines compounds as inhibitors of PCDD/Fs de novo formation on sintering process fly ash. | 2002 Jun 15 |
|
Sustaining pattern of phenformin hydrochloride using various polymers and waxes. | 2002 Sep-Oct |
|
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. | 2003 Apr 22 |
|
The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. | 2003 Aug 27 |
|
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro. | 2003 Dec 1 |
|
Dynamic localization of SPE-9 in sperm: a protein required for sperm-oocyte interactions in Caenorhabditis elegans. | 2003 Dec 3 |
|
Expression and function of bradykinin receptors in microglia. | 2003 Feb 21 |
|
A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord. | 2003 Jul 25 |
|
Preliminary assessment of alginic acid as a factor buffering triethanolamine interacting with artificial skin sebum. | 2003 Mar |
|
Substantial increase of the ordering temperature for [MnII/MoIII(CN)7]-based magnets as a function of the 3d ion site geometry: example of two supramolecular materials with Tc = 75 and 106 K. | 2003 Mar 10 |
|
Modification and validation of the pyromellitic acid electrolyte for the capillary electrophoretic determination of anions. | 2003 May 2 |
|
Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. | 2003 May-Jun |
|
The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin. | 2003 Nov |
|
Extracting material parameters from x-ray attenuation: a CT feasibility study using kilovoltage synchrotron x-rays incident upon low atomic number absorbers. | 2003 Oct 21 |
|
Determination of alkanolamines in cattails (Typha latifolia) utilizing electrospray ionization with selected reaction monitoring and ion-exchange chromatography. | 2004 |
|
Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. | 2004 Apr 15 |
|
[The problem and improvement of colorimetric method for determination of sulfite in foods containing sulfur compounds]. | 2004 Dec |
|
Mixture additives inhibit the dermal permeation of the fatty acid, ricinoleic acid. | 2004 Feb 28 |
|
Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines. | 2004 Jan |
|
Rheological characterization of topical carbomer gels neutralized to different pH. | 2004 Jul |
|
Lactic acid production with lactate dehydrogenase using the visible light sensitization of zinc porphyrin. | 2004 Jul |
|
[Contact sensitization to pharmaceutic aids in dermatologic cosmetic and external use preparations]. | 2004 May |
|
Titanatranes derailed: static and dynamic triethanolamine slippage induced by polyphenoxide chelation. | 2004 Nov 1 |
|
A high-nuclearity "Celtic-ring" isopolyoxotungstate, [H12W36O120]12-, that captures trace potassium ions. | 2004 Nov 3 |
|
Determination of diethanolamine or N-methyldiethanolamine in high ammonium concentration matrices by capillary electrophoresis with indirect UV detection: application to the analysis of refinery process waters. | 2004 Sep |
Sample Use Guides
Fill ear canal with ear drops of 10% triethanolamine Polypeptide Oleate-Condensate with the patient’s head tilted at a 45° angle. Insert cotton plug and allow to remain 15-30 minutes. Then gently flush with lukewarm water, using a soft rubber syringe (avoid excessive pressure). Exposure of skin outside the ear to the drug should be avoided. The procedure may be repeated if the first application fails to clear the impaction.
Route of Administration:
Otic (auricular)
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/?term=15850295
Penetration of triethanolamine into artificial skin sebum and its uplift were measured using 0.1 M aqueous triethanolamine solution.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:03:16 GMT 2023
by
admin
on
Fri Dec 15 16:03:16 GMT 2023
|
Record UNII |
9O3K93S3TK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
D03AX12
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
||
|
EPA PESTICIDE CODE |
4208
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2768
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
CHEMBL446061
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
m11100
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | Merck Index | ||
|
TRIETHANOLAMINE
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
203-049-8
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
561
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
28621
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
SUB12376MIG
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
9O3K93S3TK
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
DTXSID9021392
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
1696958
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
38623
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB13747
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
100000079034
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
36718
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
9O3K93S3TK
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
C009546
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
7618
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
C80948
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
102-71-6
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY | |||
|
893
Created by
admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|